Global Genome Editing Market Forecast to 2025

  • March, 2019
  • Domain: Healthcare - Biotechnology
Pages: 97
Tables: 42
Charts: 30
Regions/Countries: 4 / 0
Companies: 12
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

[98 pages report] This market research report includes a detailed segmentation of the global genome editing market – by technology (CRISPR, TALEN, ZFN, and Others), by application (Cell Line Engineering, Genetic Engineering, and Others), By end-user (Research Institutes, Biotechnology and Pharmaceutical Companies, and Contract Research Organizations), by regions (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global Genome Editing Market

Infoholic’s market research report predicts that the “Global Genome Editing Market” will grow at a CAGR of 14.4% during the forecast period. The market has witnessed steady growth in the past few years with the development in technology and the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled due to increase in genetic disorders, increasing investment and funds, and technological advancements in genome editing.

Global Genome Editing Market

The market continues to grow and is one of the increasingly accepted market in many countries worldwide. Vendors are focusing towards obtaining funds and collaborating with universities to enlarge their research and development capabilities. The majority of the revenue is generated from the leading players in the market with dominating sales of ThermoFisher Scientific, GenScript Corp., Sangamo Therapeutics, Lonza Group, and Horizon Discovery Group plc.

According to Infoholic Research analysis, North America accounted for the largest share of the global genome editing market in 2018. US dominates the market with majority of genome editing companies being located in this region. However, China has not been too far behind and has great government support for the research in genome editing field.

Genome Editing Market by Technology:



  • ZFN

  • Others


In 2018, the CRISPR segment occupied the largest share due to specific, effective, and cost-effective nature of the technology. Many companies are focusing on providing genome editing services. For instance, in January 2019, Horizon Discovery extended CRISPR screening service to primary human T cells.

Genome Editing Market by Applications:


  • Cell Line Engineering

  • Genetic Engineering

  • Others


In 2018, the cell line engineering accounted the maximum share followed by genetic engineering. Increase in the number of people suffering with genetic disorders has driven the growth of the genome editing market.

Genome Editing Market by End Users:



  • Research Institutes

  • Biotechnology and Pharmaceutical Companies

  • Contract Research Organizations


In 2018, the biotechnology and pharmaceutical companies gained the highest market share for genome editing market due to increased pervasiveness of cancer and infectious diseases are driving research goings-on in biotechnology & pharmaceutical companies segment.

Genome Editing Market by Regions:



  • North America

  • Europe

  • APAC

  • ROW


The market is dominated by North America, followed by Asia Pacific and Europe. The major share of the North America market is from the US due to quick adoption of new and advanced technologies.

Genome Editing Market Research Competitive Analysis – The market is extremely fragmented with several smaller companies struggling for market share. Big pharmaceutical establishments have also united with venture capitalists to provide funding to the start-ups. In 2015, Bayer financed $335 million and in the very same year, Celgene combined with Abingworth invested $64 million in CRISPR Therapeutics. The NIH recently granted 21 somatic cell genome editing grants of almost $86 million over the next half a decade. These endowments are the foremost to be granted through the Somatic Cell Genome Editing (SCGE) program that was initiated in January 2018 with NIH Common Fund.

The companies are collaborating and licensing to increase their capabilities in the market. CRISPR, TALEN, ZFN, Meganuclease, ARCUS, and RTDS are some of the key technology areas concentrated by key players in the market. Since 2015, the deals on the CRISPR technology has drastically increased.

Key vendors:



  • ThermoFisher Scientific

  • GenScript Corp.

  • Sangamo Therapeutics

  • Lonza Group

  • Horizon Discovery Group plc

  • Merck KGaA

  • Transposagen Biopharmaceutical

  • CRISPR Therapeutics

  • Editas Medicine

  • Integrated DNA Technologies

  • New England Biolabs

  • Origene Technologies, Inc.


Key competitive facts –



  • Genetic editing technologies are intensely evolving from previous two decades and has facilitated in the variation of genome further rapidly and in a less expensive technique.

  • The US is the leader in the CRISPR technology, while the market for TALEN genome editing technology is dominated by China.


Benefits – The report provides complete details about the usage and adoption rate of genome editing market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the healthcare segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:



  • Understanding the potential market opportunity with precise market size and forecast data

  • Detailed market analysis focusing on the growth of genome editing industry

  • Factors influencing the growth of genome editing market

  • In-depth competitive analysis of dominant and pureplay vendors

  • Prediction analysis of genome editing market in both developed and developing regions

  • Key insights related to major segments of the genome editing market

  • Latest market trend analysis impacting the buying behavior of the consumers


Key Stakeholders

Genome Editing Market


1      Industry Outlook

1.1        Industry Overview

1.2        Total Addressable Market

1.2.1      Industry Trends

2      Report Outline

2.1        Report Scope

2.2        Report Summary

2.3        Research Methodology

2.4        Report Assumptions

3      Market Snapshot

3.1        Market Definition – Infoholic Research

3.2        Segmented Addressable Market (SAM)

3.3        Industry Trends

3.4        Related Markets

3.4.1      Genetic Testing  Trends of the genetic testing market

3.4.2      Liquid Biopsy Market  Trends of Liquid biopsy market

3.4.3      Next-generation sequencing  Trends in the Next-generation sequencing market

4      Market Outlook 

4.1        Funding Scenario

4.2        International Patent Classification (IPC) Codes and for the Technology Areas

4.2.1      Life Science Research

4.2.2      General Research

4.3        Deals

4.4        Porter 5 (Five) Forces

5      Market Characteristics

5.1        Evolution

5.2        Market Segmentation

5.3        Market Dynamics

5.3.1      Drivers  Increase in Genetic Disorders  Increasing Investment and Funds  Technological Advancements in Genome Editing

5.3.2      Restraints  Ethical Concerns Associated to Genetic Editing  High Cost of Genome Engineering Technologies

5.3.3      Opportunities  Market Expansion Opportunities in Emerging Nations  Growing Collaboration for Genome Engineering Technologies

5.3.4      DRO – Impact Analysis

5.4        Key Stakeholders

6      Technology Types: Market Size and Analysis

6.1        Overview

6.2        CRISPR/Clustered Regularly Interspaced Short Palindromic Repeats

6.3        TALEN/Transcription Activator-Like Effector Nuclease

6.4        ZFN/Zinc-Finger Nucleases

6.5        Others

7      Application Types: Market Size and Analysis

7.1        Overview

7.2        Cell Line Engineering

7.3        Genetic Engineering

7.4        Others

8      End Users: Market Size and Analysis

8.1        Overview

8.2        Research Institutes

8.3        Biotechnology and Pharmaceutical Companies

8.4        Contract Research Organizations

9      Regions: Market Size and Analysis

9.1        Overview

9.2        North America

9.2.1      Overview

9.3        Europe

9.3.1      Overview

9.4        Asia Pacific

9.4.1      Overview

9.5        Rest of the World

9.5.1      Overview

10   Competitive Landscape

11   Vendors Profile

11.1      ThermoFisher Scientific, Inc.

11.1.1    Overview

11.1.2    Business Units

11.1.3    Geographic Presence

11.1.4    Business Focus

11.1.5    SWOT Analysis

11.1.6    Business Strategy

11.2      GenScript Corp.

11.2.1    Overview

11.2.2    Business Units

11.2.3    Geographic Presence

11.2.4    Business Focus

11.2.5    SWOT Analysis

11.2.6    Business Strategies


11.3.1    Overview

11.3.2    Business Focus

11.3.3    SWOT Analysis

11.3.4    Business Strategies

11.4      Lonza Group

11.4.1    Overview

11.4.2    Business Units

11.4.3    Geographic Presence

11.4.4    Business Focus

11.4.5    SWOT Analysis

11.4.6    Business Strategies

11.5      Horizon Discovery Group plc

11.5.1    Overview

11.5.2    Business Units

11.5.3    Geographic Presence

11.5.4    Business Focus

11.5.5    SWOT Analysis

11.5.6    Business Strategies

12   Companies to Watch for

12.1      Merck KGaA

12.1.1    Overview

12.2      Transposagen Biopharmaceuticals

12.2.1    Overview

12.3      CRISPR Therapeutics

12.3.1    Overview

12.4      Editas Medicine

12.4.1    Overview

12.5      Integrated DNA Technologies

12.5.1    Overview

12.6      New England Biolabs

12.6.1    Overview

12.7      Origene Technologies, Inc.

12.7.1    Overview



Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License


Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Related Reports